glp 1 medullary thyroid cancer GLP-1 medications and risk Increased screening may lead to

That said, studies like this can still be valuable as an early signal

Comparative effectiveness of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas for sight-threatening diabetic retinopathy

Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Desire an FDA-approved, well-tolerated non-surgical weight loss treatment Who Should Not Use GLP-1 Medications These medications are not appropriate for patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2)

N Engl J Med 2024

This helps many patients lose weight and control blood sugar